11:04 AM EDT, 07/09/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.59% to 1,501.77 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Grifols ( GRFS ) and DBV Technologies ( DBVT ) , which advanced 6.9% and 6.1%, respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and pharmaceutical company Ascendis Pharma ( ASND ) , which rose 5.8% and 4.8%, respectively.

The decliners from continental Europe were led by telecommunications company Ericsson (ERIC) and biopharmaceutical company Cellectis ( CLLS ) , which fell 3.6% and 2.5%, respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and telecommunications company Nokia ( NOK ) , which were down 2.1% and 1.5%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma ( VRNA ) and NuCana ( NCNA ) , which climbed 21% and 19%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and biotech firm Autolus Therapeutics ( AUTL ) , which increased 6.5% and 5.7%, respectively.

The decliners from the UK and Ireland were led by communications company WPP ( WPP ) and software firm Endava ( DAVA ) , which dropped 17% and 3.3%, respectively. They were followed by insurance company Prudential (PUK) and biotech firm Trinity Biotech ( TRIB ) , which lost 1.7% and 1.6%, respectively.